Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 January 2018 Photo Charl Devenish
Researcher tackling drug-resistant TB through molecular methods
Dr Anneke van der Spoel van Dijk is invested in contributing to the global effort of stopping TB by 2035.

The work of Dr Anneke van der Spoel van Dijk investigates the spread of TB in the Free State population using techniques such as next generation sequencing, spoligotyping and MIRU-VNTR typing. Dr Van der Spoel van Dijk, a senior medical scientist in the Department of Medical Microbiology at the University of the Free State (UFS) also looks at drug resistance in her research. This work informs decisions about how best to treat patients with multidrug-resistant TB (MDR-TB). 

She employs rapid molecular techniques to track one of Africa’s most serious diseases, tuberculosis (TB). 

Drug resistance
Scientists assist the National Health Laboratory Service and Department of Health in trying to refine the diagnostic tools to identify these cases earlier. Dr Van der Spoel van Dijk explains: “Until recently, it took up to two years to fine-tune treatment decisions for patients with MDR-TB. Patients get a cocktail of anti-TB drugs, but it takes time to find the right combination. Re-infection and relapse (patients stopping treatment for several reasons) add to the diagnostic and treatment management challenges.

Enormous impact
“Now doctors can reduce the time needed for diagnostic certainty to about seven days, while new drugs allow reduction of treatment from more than 18 to nine months. This can have an enormous impact on the life of many patients.”

Dr Van der Spoel van Dijk’s work forms part of research in the faculty looking at resistance development in TB strains. She is currently also doing her doctoral thesis on the differences and incidence of MDR-TB among adolescents versus adults. Dr Van der Spoel van Dijk says: “It is a complicated picture, but we hope to unravel it to support better diagnostic tools and patient care.”

As part of the National Health Laboratory Service, her department is playing an important role in TB diagnostics and the training of scientists and future pathologists. “Our work is contributing to the global vision to stop TB by 2035,” Dr Van der Spoel van Dijk says.

News Archive

Our 2014/15 male and female Rag finalists announced
2014-11-10

More than 100 applied. Only 20 remain.

From the ranks of the semi-finalists – who managed to raise an astonishing R250 000.00 for the Kovsie Rag CS (Receive and Give Community Service) – we now have the names of our 20 finalists.

The Brutal Fruit UFS Rag CS Queen finalists are:

  • Ansunel Schutte
  • Carla de Bruyn
  • Chante Marais
  • Charissa Venter
  • Diederi Venter
  • Erne van Wyk
  • Karen Janse van Rensburg
  • Mia van Rensburg
  • Selebogo Lekalake
  • Stephanie Enslin

The Brutal Fruit UFS Mr Rag CS finalists are:

  • Marcques Fourie
  • Americo Lottering
  • Brandon van Wyk
  • Danzel Rademan
  • Kabelo Mashabe
  • Ludwig Dohne
  • Marius Croucamp
  • Thomas Kolathu
  • Spurgeon Pijoos
  • Wilmar van Niekerk

These 20 finalists had to choose a charity or organization for which they will continue to raise funds. With the support of the public and business sector, these young men and women will be able to continue to make a difference in our community.

With a current turnover of about R5.5 million, we are today reckoned as the largest Rag CS per capita in South Africa. Goods and/or money to the value of R2 million were distributed by Kovsie Rag CS during the 2013/14 book year – to the benefit of numerous charities.

The annual Brutal Fruit UFS Rag CS Coronation Ball has become a highlight on the Free State’s social calendar. The UFS RAG CS Queen and UFS Mr RAG CS 2015 will be crowned at this lustrous event on 13 February 2015.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept